0
Orphan Designations
1
FDA Approvals
Latest: MYOBLOC (2000)
0
Active Trials
4
Rare Diseases
across 4 areas
0
News (30d)
Quiet
Solstice Neurosciences, LLC is a company with 0 orphan drug designations across 4 rare diseases, including 1 FDA-approved therapy.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| benign essential blepharospasm | MYOBLOC | Des.TrialAppr. |
| cervical dystonia | MYOBLOC | Des.TrialAppr. |
| clonic hemifacial spasm | MYOBLOC | Des.TrialAppr. |
| combined cervical dystonia | MYOBLOC | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
4
overlap in 2+ diseases
0/4
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
4
overlap in 2+ diseases
0/4
candidate diseases
0
avg importance: 0
0
affecting portfolio